Im­mu­ni­ty­Bio, Coda­genix and Eu­Men­tis raise funds, while a biotech SPAC dis­solves

While Im­mu­ni­ty­Bio is in­volved in ar­bi­tra­tion with Sor­ren­to Ther­a­peu­tics, which filed for bank­rupt­cy this week to pro­tect from the po­ten­tial cap­i­tal bur­den, the Cal­i­for­nia …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER